应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
LLY 礼来
休市中 12-20 15:59:59 EST
768.04
+10.50
+1.39%
盘后
767.76
+0.00
0.00%
19:59 EST
最高
811.35
最低
766.61
成交量
994.23万
今开
811.35
昨收
757.54
日振幅
5.91%
总市值
7,291亿
流通市值
7,281亿
总股本
9.49亿
成交额
78.50亿
换手率
1.05%
流通股本
9.48亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
礼来Zepbound获FDA批准 可用于治疗阻塞性睡眠呼吸暂停
市场资讯 · 04:45
礼来Zepbound获FDA批准 可用于治疗阻塞性睡眠呼吸暂停
诺和诺德跌倒,礼来独霸减肥药?
华尔街见闻 · 12-21 15:50
诺和诺德跌倒,礼来独霸减肥药?
礼来“减肥神药”获FDA批准,成首款用于治疗睡眠呼吸暂停药物
智通财经 · 12-21 10:20
礼来“减肥神药”获FDA批准,成首款用于治疗睡眠呼吸暂停药物
BUZZ-美股周报:暴风雪
路透中文 · 12-21 05:28
BUZZ-美股周报:暴风雪
礼来上涨2.96%,报779.95美元/股
金融界 · 12-21 02:59
礼来上涨2.96%,报779.95美元/股
BUZZ--美国股票走势-Mission Produce、Sirius XM、嘉年华公司
Reuters · 12-20 23:39
BUZZ--美国股票走势-Mission Produce、Sirius XM、嘉年华公司
诺和诺德跌倒,竞争对手能“吃饱”吗?礼来、安进等股小幅走高
老虎资讯综合 · 12-20 23:14
诺和诺德跌倒,竞争对手能“吃饱”吗?礼来、安进等股小幅走高
礼来一度涨超7%,竞争对手诺和诺德减肥药试验结果不及预期
市场资讯 · 12-20 23:00
礼来一度涨超7%,竞争对手诺和诺德减肥药试验结果不及预期
背景资料-减肥药开发商排队开发价值 1500 亿美元的市场
Reuters · 12-20 22:59
背景资料-减肥药开发商排队开发价值 1500 亿美元的市场
礼来涨4.25% 股价突破800美元大关
市场透视 · 12-20 22:33
礼来涨4.25% 股价突破800美元大关
礼来(LLY.N)涨超4%,竞争对手诺和诺德的减肥药试验结果不及预期。
美港电讯 · 12-20 22:32
礼来(LLY.N)涨超4%,竞争对手诺和诺德的减肥药试验结果不及预期。
BUZZ--美国股票走势-Humacyte、Ionis 制药公司、Emeren 集团
路透中文 · 12-20 22:12
BUZZ--美国股票走势-Humacyte、Ionis 制药公司、Emeren 集团
减肥药巨震!诺和诺德盘前暴跌、礼来大涨
中国基金报 · 12-20 22:07
减肥药巨震!诺和诺德盘前暴跌、礼来大涨
诺和诺德崩跌近20%!下一代减肥药数据不及预期 礼来闻讯大涨
东方财富 · 12-20 20:55
诺和诺德崩跌近20%!下一代减肥药数据不及预期 礼来闻讯大涨
Zealand Pharma 首席执行官称诺和诺德的 CagriSema 数据支持卡格列净单药治疗方法
路透中文 · 12-20 20:10
Zealand Pharma 首席执行官称诺和诺德的 CagriSema 数据支持卡格列净单药治疗方法
诺和诺德将在新试验中探索 CagriSema 的减肥潜力
路透中文 · 12-20 20:09
诺和诺德将在新试验中探索 CagriSema 的减肥潜力
BUZZ--美国股票走势-联邦快递、礼来公司、Aadi 生物科学公司
Reuters · 12-20 20:04
BUZZ--美国股票走势-联邦快递、礼来公司、Aadi 生物科学公司
BUZZ-诺和诺德肥胖症药物在研究中表现不佳,减肥药开发商获益匪浅
Reuters · 12-20 19:40
BUZZ-诺和诺德肥胖症药物在研究中表现不佳,减肥药开发商获益匪浅
礼来减肥药试验结果不及预期
金吾资讯 · 12-20 19:39
礼来减肥药试验结果不及预期
美股异动丨新药减重效果不及预期 诺和诺德盘前暴跌近30% 礼来涨超12%
港股那点事 · 12-20 19:24
美股异动丨新药减重效果不及预期 诺和诺德盘前暴跌近30% 礼来涨超12%
加载更多
公司概况
公司名称:
礼来
所属市场:
NYSE
上市日期:
--
主营业务:
礼来公司于1901年在印第安纳州注册成立,其前身是1876年由伊利·礼来上校在印第安纳州印第安纳波利斯创立的药品生产企业。公司发现,开发,制造和销售重要医药产品。公司的宗旨是将“关爱”与“发现”结合起来,为世界各地的人们创造更美好的生活。
发行价格:
--
{"stockData":{"symbol":"LLY","market":"US","secType":"STK","nameCN":"礼来","latestPrice":768.04,"timestamp":1734728399999,"preClose":757.54,"halted":0,"volume":9942293,"hourTrading":{"tag":"盘后","latestPrice":767.76,"preClose":767.76,"latestTime":"19:59 EST","volume":1225031,"amount":940824348.289596,"timestamp":1734742791980},"delay":0,"floatShares":948000000,"shares":949315694,"eps":9.249143,"marketStatus":"休市中","marketStatusCode":7,"change":10.5,"latestTime":"12-20 15:59:59 EST","open":811.35,"high":811.35,"low":766.61,"amount":7850209161.01769,"amplitude":0.05906,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":9.249143,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"listingDate":102488400000,"adjPreClose":757.54,"adrRate":0,"dividendRate":0.006549,"preHourTrading":{"tag":"盘前","latestPrice":812.91,"preClose":757.54,"latestTime":"09:29 EST","volume":544644,"amount":427477590.21456,"timestamp":1734704999043},"postHourTrading":{"tag":"盘后","latestPrice":767.76,"preClose":767.76,"latestTime":"19:59 EST","volume":1225031,"amount":940824348.289596,"timestamp":1734742791980},"volumeRatio":2.7926945643445418,"impliedVol":0.3579,"impliedVolPercentile":0.6706},"requestUrl":"/m/hq/s/LLY","defaultTab":"news","newsList":[{"id":"2493663802","title":"礼来Zepbound获FDA批准 可用于治疗阻塞性睡眠呼吸暂停","url":"https://stock-news.laohu8.com/highlight/detail?id=2493663802","media":"市场资讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493663802?lang=zh_cn&edition=full","pubTime":"2024-12-22 04:45","pubTimestamp":1734813900,"startTime":"0","endTime":"0","summary":" 当地时间周五,美国食品和药品管理局批准礼来公司的减肥药物Zepbound用于治疗阻塞性睡眠呼吸暂停,使其成为首个获批直接治疗这一常见睡眠障碍的药物。 据礼来公司称,Zepbound被批准用于治疗患有肥胖症的成人中度至重度OSA,在临床试验中,近一半的中度至重度OSA患者在使用Zepbound后症状完全消失。OSA患者在睡眠时会短暂停止呼吸,干扰睡眠周期,并可能引发心脏疾病等长期并发症。诺和诺德已向FDA申请批准Wegovy用于治疗慢性肾病。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2024-12-22/doc-ineahnvc4171821.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SGXZ99366536.SGD","LU0471298694.HKD","LU2468319806.SGD","LU1868837136.USD","BK4516","LU1712237335.SGD","IE00BFTCPJ56.SGD","SG9999015986.USD","BK4585","LU1069344957.HKD","BK4533","LU0061475181.USD","SG9999001176.USD","SG9999014906.USD","LU1988902786.USD","LU2112291526.USD","LU0289739699.SGD","LU2237443978.SGD","LLY","LU0238689110.USD","SG9999014898.SGD","LU0256863902.USD","LU0354030438.USD","IE00BJJMRZ35.SGD","LU0882574055.USD","LU2237443382.USD","LU1366192091.USD","SG9999018865.SGD","LU2264538146.SGD","LU2237443622.USD","LU1814569148.SGD","LU2361044949.HKD","IE00B2B36J28.USD","BK4588","LU0471298777.SGD","LU0097036916.USD","LU0417517546.SGD","LU1093756168.USD","SGXZ51526630.SGD","BK4599","LU0094547139.USD","LU0109391861.USD","LU0820561909.HKD","LU1551013342.USD","LU2360106947.USD","LU0256863811.USD","LU0820561818.USD","LU1623119135.USD","LU1868836757.USD","LU0385154629.USD"],"gpt_icon":1},{"id":"2493287728","title":"诺和诺德跌倒,礼来独霸减肥药?","url":"https://stock-news.laohu8.com/highlight/detail?id=2493287728","media":"华尔街见闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493287728?lang=zh_cn&edition=full","pubTime":"2024-12-21 15:50","pubTimestamp":1734767401,"startTime":"0","endTime":"0","summary":"诺和诺德遭遇\"滑铁卢\",新药效果不及预期引发股价暴跌。减肥药市场格局悄然生变,礼来会成为单寡头么。","market":"hk","thumbnail":"https://wpimg-wscn.awtmt.com/ff1a2d1c-4c9d-41bb-8234-e3815bd88554.png","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/ff1a2d1c-4c9d-41bb-8234-e3815bd88554.png"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3737516","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3737516","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["GB00BDT5M118.USD","LU1023059063.AUD","LU2237443549.SGD","IE00BJT1NW94.SGD","LU0106261372.USD","LU1267930730.SGD","BK4516","LU0203202063.USD","LU1868837136.USD","LU2491049909.HKD","LU0417517546.SGD","LU0256863902.USD","LU0672654240.SGD","LU0238689110.USD","IE00B4R5TH58.HKD","LU0689472784.USD","LU0882574055.USD","LU1057294990.SGD","LU1868836914.USD","LU2211815571.USD","LU2491050154.USD","LU2324357040.USD","LU2361045086.USD","LU1983299246.USD","LU2360106947.USD","IE00BFTCPJ56.SGD","SG9999014880.SGD","LU1093756325.SGD","LU2237443465.HKD","LU1366192091.USD","LU0640476718.USD","LLY","LU2361044949.HKD","SG9999015986.USD","LU0006306889.USD","LU0094547139.USD","LU0122379950.USD","LU1974910355.USD","LU0320765059.SGD","LU0354030511.USD","LU1551013425.SGD","NVO","LU0198837287.USD","LU1804176565.USD","LU0466842654.USD","SG9999014914.USD","LU0154236417.USD","BK4585","IE00BJLML261.HKD","LU1291159041.SGD"],"gpt_icon":1},{"id":"2493140214","title":"礼来“减肥神药”获FDA批准,成首款用于治疗睡眠呼吸暂停药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2493140214","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493140214?lang=zh_cn&edition=full","pubTime":"2024-12-21 10:20","pubTimestamp":1734747630,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,礼来的重磅减肥药Zepbound在美国获得批准,成为首个治疗睡眠呼吸暂停的药物,为这种重磅药物扩大保险覆盖范围打开了大门。该公司在一份声明中表示,该药物已被批准用于中度至重度阻塞性睡眠呼吸暂停和肥胖患者,应与饮食和运动结合使用。Zepbound的新批准是基于两项针对肥胖和阻塞性睡眠呼吸暂停患者的后期试验,这些试验在一年的时间里将该药的使用与安慰剂的使用进行了比较。","market":"sh","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"da5b9a6e690b527b2109f1548464cd3a","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1228060.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B4R5TH58.HKD","IE0002141913.USD","LU1868836591.USD","LU0094547139.USD","LU2023250504.SGD","LU1712237335.SGD","SGXZ51526630.SGD","LU0096364046.USD","LU1974910355.USD","LU0203202063.USD","LU0471298777.SGD","LU1804176565.USD","LU0417517546.SGD","LU2237443549.SGD","SG9999017495.SGD","LU0256863902.USD","BK4581","LU1093756325.SGD","LU1917777945.USD","BK4585","IE00B1BXHZ80.USD","LU2237443978.SGD","LU2211815571.USD","BK4534","LU2360106947.USD","LLY","LU2237443895.HKD","LU2106854487.HKD","LU0109391861.USD","LU1127390331.HKD","LU0882574055.USD","LU1623119135.USD","LU0114720955.EUR","LU2264538146.SGD","LU0943347566.SGD","SG9999015952.SGD","LU0385154629.USD","BK4588","LU0256863811.USD","LU0097036916.USD","LU1069344957.HKD","LU1814569148.SGD","LU2265009873.SGD","IE00BFTCPJ56.SGD","SG9999013999.USD","SG9999015986.USD","LU2324357040.USD","LU0708995401.HKD","LU0466842654.USD","LU2237443622.USD"],"gpt_icon":0},{"id":"2493474889","title":"BUZZ-美股周报:暴风雪","url":"https://stock-news.laohu8.com/highlight/detail?id=2493474889","media":"路透中文","labels":["event"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493474889?lang=zh_cn&edition=full","pubTime":"2024-12-21 05:28","pubTimestamp":1734730127,"startTime":"0","endTime":"0","summary":"** 能源.SPNY下挫5.6%。中国经济数据再次引发需求担忧,能源板块下跌 ,投资者对美联储利率决定保持谨慎。** 工业.SPLRCI下跌2.6%。** 消费类.SPLRCD下跌2.6%。DRI以12.5%的周涨幅轻松成为SPX指数中表现最好的股票。** 消费品.SPLRCS下跌2.5%。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nL4S3NL1AS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFSS7M15.SGD","LU0496365809.HKD","LU0642271901.SGD","IE0004445015.USD","LU2360106947.USD","LU1057294990.SGD","LU0048573561.USD","LU2552382132.HKD","LU0211331839.USD","LW","IE00B894F039.SGD","IE00B775H168.HKD","LU1551013425.SGD","LU2360106780.USD","NKE","LU1003077747.HKD","IE00BKPKM429.USD","LU0385154629.USD","BK4581","FDX","LU1791710400.SGD","LU0187121727.USD","SG9999002232.USD","SG9999017495.SGD","UNH","LU1878469433.USD","LU1917777945.USD","HON","DRI","BK4588","HUM","LU1061106388.HKD","CVS","IE00B1BXHZ80.USD","LU2133065610.SGD","LU1732800096.USD","LLY","LU2063271972.USD","LU2089283258.USD","SG9999015986.USD","LU2023250504.SGD","LU0348723411.USD","BK4566","IE00B2B36J28.USD","BK4141","LU2023251221.USD","IE00B19Z9Z06.USD","MU","GIS","LU0203202063.USD"],"gpt_icon":1},{"id":"2493478940","title":"礼来上涨2.96%,报779.95美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2493478940","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493478940?lang=zh_cn&edition=full","pubTime":"2024-12-21 02:59","pubTimestamp":1734721183,"startTime":"0","endTime":"0","summary":"12月21日,礼来(LLY)盘中上涨2.96%,截至02:59,报779.95美元/股,成交46.0亿美元。财务数据显示,截至2024年09月30日,礼来收入总额315.1亿美元,同比增长27.21%;归母净利润61.8亿美元,同比增长102.58%。大事提醒:2025年2月4日,礼来将披露2024财年年报(数据来源于纳斯达克官网,预计披露日期为美国当地时间,实际披露日期以公司公告为准)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221030234ab87d21b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221030234ab87d21b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999017495.SGD","LU0058720904.USD","LU2361044949.HKD","LU0096364046.USD","LU0640476718.USD","LU0256863902.USD","LU1061106388.HKD","LU1868837136.USD","LU1868836914.USD","LU1064131342.USD","LU0471298694.HKD","LU1551013425.SGD","LU1093756168.USD","LU0354030438.USD","LU1291159041.SGD","LU1983299246.USD","BK4516","LU1804176565.USD","LU1917777945.USD","SG9999001176.USD","LU2237443465.HKD","LLY","SGXZ57979304.SGD","LU0354030511.USD","LU2237438978.USD","LU1712237335.SGD","LU2264538146.SGD","SG9999014880.SGD","LU2324357040.USD","LU1974910355.USD","LU2237443895.HKD","LU2468319806.SGD","LU2361045086.USD","SG9999018857.SGD","IE0009355771.USD","LU2491050071.SGD","LU0122379950.USD","LU1069344957.HKD","LU2211815571.USD","LU1989771016.USD","LU0466842654.USD","SG9999013999.USD","BK4588","LU0203202063.USD","LU2491050154.USD","IE00BJJMRZ35.SGD","LU2023250504.SGD","LU0943347566.SGD","BK4533","LU2237443622.USD"],"gpt_icon":0},{"id":"2492440770","title":"BUZZ--美国股票走势-Mission Produce、Sirius XM、嘉年华公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2492440770","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492440770?lang=zh_cn&edition=full","pubTime":"2024-12-20 23:39","pubTimestamp":1734709181,"startTime":"0","endTime":"0","summary":" * 个股走势的 Eikon 搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 12月20日 - 标普500指数和纳斯达克指数周五下跌,原因是市场担心明年的高利率问题,尽管一份冷于预期的通胀报告抑制了损失。美国东部时间10:30,道琼斯工业平均指数 上涨0.61%,报42601.62点。标普500指数 上涨0.49%,报5895.94点;纳斯达克综合指数 上涨0.44%,报19457.30点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FDS","AADI","WGO","FDX","USJW.SI","SIRI",".SPX","KMX","DNMR","DDM","MNQmain","KUKE","SNPS","IIPR","VKTX","QID",".DJI","IONS","DJX","GALT","AMGN","NVIW.SI","ALT","SQQQ",".IXIC","CCL","XM","SOL","X","TSYW.SI","CLW","NQmain","USAW.SI","GPCR","HUMA","PSQ","SDOW","MRK","TQQQ","APLM","VNCE","DOG","NVO","LLY","QLD","AVO","DXD"],"gpt_icon":1},{"id":"1151227836","title":"诺和诺德跌倒,竞争对手能“吃饱”吗?礼来、安进等股小幅走高","url":"https://stock-news.laohu8.com/highlight/detail?id=1151227836","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151227836?lang=zh_cn&edition=full","pubTime":"2024-12-20 23:14","pubTimestamp":1734707684,"startTime":"0","endTime":"0","summary":"CagriSema减重效果低于预期。","market":"us","thumbnail":"https://static.tigerbbs.com/64d7f8b1a0687a6bf124201afc1b1baa","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/64d7f8b1a0687a6bf124201afc1b1baa"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"诺和诺德跌倒,竞争对手能“吃饱”吗?礼来、安进等股周五齐涨","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN","VKTX","LLY","NVO"],"gpt_icon":0},{"id":"2492447694","title":"礼来一度涨超7%,竞争对手诺和诺德减肥药试验结果不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2492447694","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492447694?lang=zh_cn&edition=full","pubTime":"2024-12-20 23:00","pubTimestamp":1734706800,"startTime":"0","endTime":"0","summary":"格隆汇12月20日|礼来(LLY.US)盘初涨超7%报811.35美元。消息面上,诺和诺德周五公布了一项名为REDEFINE 1的三期临床试验的主要结果。在评估所有人都坚持治疗的治疗效果时,使用CagriSema治疗的患者在68周后体重减轻22.7%,低于市场预期的25%。诺和诺德股价暴跌超20%。(格隆汇)\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:郭明煜","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4de5f7200a34a5a69d5dce1d967bfe14","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2024-12-20/doc-ineacsyf2766389.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0289739699.SGD","LU2023250504.SGD","LU0122379950.USD","LU0456855351.SGD","LU0471298777.SGD","SG9999017495.SGD","SG9999014906.USD","IE00B1BXHZ80.USD","IE00B2B36J28.USD","LU1983299246.USD","SG9999014898.SGD","SGXZ57979304.SGD","LU1712237335.SGD","LLY","BK4533","LU1035775433.USD","LU1804176565.USD","LU1917777945.USD","SG9999014880.SGD","LU2237443382.USD","SG9999013999.USD","SG9999015978.USD","LU0640476718.USD","LU0354030511.USD","LU1093756325.SGD","LU0256863902.USD","LU1064131342.USD","LU2237443895.HKD","LU2360106947.USD","IE0004445239.USD","BK4534","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU0672654240.SGD","IE0002141913.USD","LU1868836914.USD","LU0006306889.USD","LU2265009873.SGD","LU1551013342.USD","LU2211815571.USD","LU0354030438.USD","LU1023059063.AUD","LU1093756168.USD","LU0689472784.USD","BK4599","LU0061475181.USD","LU0058720904.USD","NVO","BK4585","LU0109391861.USD"],"gpt_icon":0},{"id":"2492544239","title":"背景资料-减肥药开发商排队开发价值 1500 亿美元的市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2492544239","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492544239?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:59","pubTimestamp":1734706761,"startTime":"0","endTime":"0","summary":"与Wegovy试验68周后体重减轻约15%相比, 。11 月,该公司称,在一项早期试验中,该药物帮助 9 名接受最高 100 毫克剂量治疗的患者在 28 天后平均减轻了 8.2% 的体重。该公司在 8 月份表示,它将在今年下半年开始与其他制药公司洽谈开发和商业化 petrelintide 的潜在合作事宜。Zealand 公司目前正在进行一项中期研究,在没有 2 型糖尿病的超重或肥胖患者中测试 petrelintide。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203201768.USD","LU1868837300.USD","SG9999002224.SGD","SG9999018865.SGD","LU2211815571.USD","LU2491050071.SGD","IE00BJT1NW94.SGD","LU0471298777.SGD","LU1868836757.USD","LU0354030511.USD","LU0708995401.HKD","LU2361045086.USD","LU0122379950.USD","LLY","LU2461242641.AUD","IE00B2B36J28.USD","LU1983299246.USD","MRK","PFE","LU0861579265.USD","SGXZ99366536.SGD","LU2361044865.SGD","LU2242652126.USD","LU2602419157.SGD","ALT","AMGN","LU0965509010.AUD","LU0466842654.USD","LU0203202063.USD","NVO","SG9999015945.SGD","LU2089984988.USD","SG9999018857.SGD","LU1093756325.SGD","LU1989772923.USD","IE00B1BXHZ80.USD","LU1037948897.HKD","IE00BJLML261.HKD","LU1941712348.USD","OPK","SGXZ57979304.SGD","IE000M9KFDE8.USD","IE00BK4W5M84.HKD","IE0002141913.USD","LU0097036916.USD","LU0079474960.USD","LU1917777945.USD","BK4534","GPCR","LU2237443382.USD"],"gpt_icon":1},{"id":"2492011444","title":"礼来涨4.25% 股价突破800美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2492011444","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492011444?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:33","pubTimestamp":1734705182,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日22时33分,礼来股票出现波动,股价大幅上涨4.25%。截至发稿,该股报789.75美元/股,成交量172.53万股,换手率0.19%,振幅3.08%。最近的财报数据显示,该股实现营业收入114.39亿美元,净利润9.70亿美元,每股收益1.08美元,毛利92.68亿美元,市盈率85.10倍。礼来股票所在的制药行业中,整体涨幅为1.57%。康希诺表示,截至目前,暂无国内疫苗厂商研发的组分百白破疫苗获批上市,公司的婴幼儿用DTcP定位即为进口替代。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223303a1fe24ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223303a1fe24ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1868836591.USD","LU2360106947.USD","LU2491050071.SGD","LU0882574055.USD","LU1064131342.USD","LU1069344957.HKD","LU2468319806.SGD","LU0820561909.HKD","LU0471298777.SGD","LU0058720904.USD","SG9999018857.SGD","LU1551013425.SGD","GB00BDT5M118.USD","IE0004445239.USD","LU0096364046.USD","LU2106854487.HKD","LU0385154629.USD","LU1974910355.USD","BK4581","LU0289739699.SGD","BK4534","LU2461242641.AUD","IE0009355771.USD","LU2237443895.HKD","SG9999017495.SGD","IE0002141913.USD","SG9999018865.SGD","LU0122379950.USD","LU0417517546.SGD","LU1917777945.USD","LU1267930730.SGD","LU2361044949.HKD","LU2211815571.USD","LU0256863902.USD","IE00B1BXHZ80.USD","SG9999015978.USD","LU0079474960.USD","LU0198837287.USD","LU2237438978.USD","LLY","LU2063271972.USD","LU0106261372.USD","LU0943347566.SGD","LU2491050154.USD","SGXZ81514606.USD","BK4599","IE00B4R5TH58.HKD","LU1868837300.USD","IE00BFTCPJ56.SGD","SG9999014880.SGD"],"gpt_icon":1},{"id":"2492441991","title":"礼来(LLY.N)涨超4%,竞争对手诺和诺德的减肥药试验结果不及预期。","url":"https://stock-news.laohu8.com/highlight/detail?id=2492441991","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492441991?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:32","pubTimestamp":1734705162,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4de5f7200a34a5a69d5dce1d967bfe14","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4007","LU0823416689.USD","LU0289739699.SGD","LU1868836757.USD","LU1551013425.SGD","SG9999015952.SGD","LU1291159041.SGD","SG9999014906.USD","LU1093756325.SGD","LU0708995401.HKD","IE00BZ1G4Q59.USD","BK4532","LU2237443549.SGD","LU0061475181.USD","LU0122379950.USD","LU0471298694.HKD","LU2089984988.USD","LU2491050071.SGD","LU1712237335.SGD","LU2237443895.HKD","LU1551013342.USD","LU1069344957.HKD","NVO","IE00BK4W5L77.USD","LU0882574055.USD","LU0943347566.SGD","LU1989771016.USD","SGXZ99366536.SGD","LU1127390331.HKD","LU1917777945.USD","LU1035775433.USD","LU2324357040.USD","LU0006306889.USD","LU0238689110.USD","GB00BDT5M118.USD","LU1974910355.USD","LU2264538146.SGD","LU2106854487.HKD","BK4599","LU2468319806.SGD","IE0009355771.USD","LU1061106388.HKD","LU1868837300.USD","IE00BJJMRZ35.SGD","LU1267930730.SGD","SG9999001176.USD","BK4534","LLY","SG9999014914.USD","LU2237443622.USD"],"gpt_icon":0},{"id":"2492449584","title":"BUZZ--美国股票走势-Humacyte、Ionis 制药公司、Emeren 集团","url":"https://stock-news.laohu8.com/highlight/detail?id=2492449584","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492449584?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:12","pubTimestamp":1734703974,"startTime":"0","endTime":"0","summary":"** 联邦快递FDX.N:BUZZ - 分析师认为联邦快递分拆货运部门是有益的;将PT升至 nL4N3NL0I5 。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nL4T3NL0VS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGO","LU0348723411.USD","IE00BJLML261.HKD","LU0094547139.USD","LU1878469433.USD","IE00B4R5TH58.HKD","X","LU0096364046.USD","LU2238339852.HKD","LU2458330169.SGD","GALT","LU0823416689.USD","LU2357305700.SGD","BK4555","LLY","LU1988902786.USD","LU0109392836.USD","LU2361044949.HKD","LU0157215616.USD","SOL","ALT","LU1429558221.USD","BK4133","SG9999015978.USD","LU0957791311.USD","LU1280957306.USD","LU0820561818.USD","LU1914381329.SGD","IONS","LU0256863902.USD","KMX","AADI","APLM","SGXZ81514606.USD","TSYW.SI","LU0310800965.SGD","AMPS","LU0466842654.USD","AMGN","SNPS","ANSS","GPCR","FDX","LU0114720955.EUR","VKTX","HUMA","SG9999015986.USD","LU0061475181.USD","LU2458330243.SGD"],"gpt_icon":1},{"id":"2492944960","title":"减肥药巨震!诺和诺德盘前暴跌、礼来大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2492944960","media":"中国基金报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492944960?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:07","pubTimestamp":1734703620,"startTime":"0","endTime":"0","summary":"受此影响,诺和诺德盘前股价一度暴跌超20%,其直接竞争对手礼来盘前股价则大涨。为了应对礼来推出的减肥药替尔泊肽的威胁,诺和诺德注册了CagriSema与替尔泊肽的头对头试验。而当供应问题不再成为阻碍后,这种均势有可能被打破,礼来有望在减肥药市场取代诺和诺德成为领导者。在业内人士看来,减肥药市场的竞争已经进入一个新阶段,礼来与诺和诺德两大制药巨头的较量日益激烈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220221056a1fe1a8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"4de5f7200a34a5a69d5dce1d967bfe14","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220221056a1fe1a8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1868836914.USD","LU2491049909.HKD","LU0471298777.SGD","BK4516","LU0061475181.USD","SGXZ81514606.USD","SG9999014914.USD","IE0002141913.USD","LU2237443549.SGD","LU1983299246.USD","LU1974910355.USD","NVO","LU2237443978.SGD","LU0882574055.USD","LU1623119135.USD","LU2264538146.SGD","GB00BDT5M118.USD","LU0708995401.HKD","LU2237443382.USD","LU0203201768.USD","LU1712237335.SGD","SGXZ31699556.SGD","LLY","LU0079474960.USD","LU0471298694.HKD","LU0882574139.USD","LU1814569148.SGD","LU0094547139.USD","LU2265009873.SGD","IE00BJLML261.HKD","LU0943347566.SGD","LU2324357040.USD","LU1989771016.USD","SGXZ51526630.SGD","LU2237438978.USD","LU0256863811.USD","LU2237443895.HKD","IE00BJJMRZ35.SGD","LU1868837136.USD","SG9999015952.SGD","SG9999018865.SGD","LU0006306889.USD","LU2237443465.HKD","LU1551013425.SGD","LU1061106388.HKD","LU0096364046.USD","LU0320765059.SGD","LU1868837300.USD","LU0238689110.USD","LU1868836591.USD"],"gpt_icon":1},{"id":"2492106410","title":"诺和诺德崩跌近20%!下一代减肥药数据不及预期 礼来闻讯大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2492106410","media":"东方财富","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492106410?lang=zh_cn&edition=full","pubTime":"2024-12-20 20:55","pubTimestamp":1734699338,"startTime":"0","endTime":"0","summary":"被誉为“减肥药双雄”的诺和诺德,周五给全球投资者表演了一把“高位跳水”。作为参照,安慰剂组减重数据为2.3%。分析师们普遍预期,CagriSema有望在2026年上市,接班司美格鲁肽成为诺和诺德下一代营收引擎。对于诺和诺德来说,更紧迫的问题是与礼来的竞争。受此消息带动,礼来周五盘前大涨近10%。值得一提的是,诺和诺德在今年9月时,也因为口服减肥药Monlunabant的试验数据不理想出现过单日大跌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220205556a1fde9b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"4de5f7200a34a5a69d5dce1d967bfe14","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220205556a1fde9b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4534","IE00BZ1G4Q59.USD","LU1989771016.USD","LU2089984988.USD","IE00BFTCPJ56.SGD","LU0471298777.SGD","LU1804176565.USD","LU0198837287.USD","LU0256863811.USD","LU1035775433.USD","LU1868836757.USD","LU2237443978.SGD","LU0289739699.SGD","IE0004445239.USD","SG9999015952.SGD","LU0256863902.USD","LU1868836914.USD","LU2112291526.USD","SG9999018865.SGD","IE00B4R5TH58.HKD","LU1868836591.USD","LU2265009873.SGD","NVO","SG9999014880.SGD","BK4585","LU2106854487.HKD","LU0640476718.USD","LU0689472784.USD","LU1551013425.SGD","LU0820561818.USD","LU2361044949.HKD","IE00BJT1NW94.SGD","LU0106261372.USD","SG9999014914.USD","LU1712237335.SGD","SGXZ51526630.SGD","LU0354030438.USD","LU1280957306.USD","LU0882574055.USD","LU0466842654.USD","IE0009355771.USD","LU2361044865.SGD","LU2461242641.AUD","LU1267930730.SGD","SG9999014898.SGD","IE00BJJMRZ35.SGD","LLY","LU2237443549.SGD","GB00BDT5M118.USD","LU2237443465.HKD"],"gpt_icon":1},{"id":"2492941476","title":"Zealand Pharma 首席执行官称诺和诺德的 CagriSema 数据支持卡格列净单药治疗方法","url":"https://stock-news.laohu8.com/highlight/detail?id=2492941476","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492941476?lang=zh_cn&edition=full","pubTime":"2024-12-20 20:10","pubTimestamp":1734696603,"startTime":"0","endTime":"0","summary":"Zealand Pharma 首席执行官称诺和诺德的 CagriSema 数据支持卡格列净单药治疗方法路透哥本哈根12月20日 - 丹麦制药商西兰制药ZELA.CO首席执行官周五表示,诺和诺德NOVOb.CO的CagriSema研究数据支持西兰制药自己的卡格列汀单药治疗方法。\"在诺和诺德公布CagriSema数据后,西兰制药首席执行官亚当-斯邓斯贝格对路透说:\"尽管CagriSema可能令市场失望,但这些数据对我们采用单一疗法治疗卡格列净的方法提供了有力支持,这使西兰制药的股价暴跌了20%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nL4S3NL0RG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014880.SGD","LU0203201768.USD","LU0672654240.SGD","LU1868836757.USD","LU0106261372.USD","IE0002141913.USD","LU0354030511.USD","LU0203202063.USD","LU1035775433.USD","BK4585","LU1623119135.USD","LU1804176565.USD","LU2461242641.AUD","LLY","SG9999018857.SGD","IE00BJJMRZ35.SGD","BK4007","SG9999015945.SGD","LU2361044949.HKD","LU1064131342.USD","IE00B1BXHZ80.USD","LU0006306889.USD","LU2602419157.SGD","LU0820561909.HKD","LU1983299246.USD","LU0109391861.USD","LU1366192091.USD","LU1280957306.USD","LU0820561818.USD","LU0256863902.USD","SG9999018865.SGD","SGXZ81514606.USD","LU0466842654.USD","SGXZ99366536.SGD","SG9999017495.SGD","LU2491050071.SGD","LU0097036916.USD","LU2360106947.USD","LU0456855351.SGD","LU0708995401.HKD","IE0004445239.USD","LU0114720955.EUR","SGXZ31699556.SGD","LU2324357040.USD","IE00BK4W5M84.HKD","LU2361044865.SGD","LU0061475181.USD","LU0417517546.SGD","IE00BJT1NW94.SGD","BK4588"],"gpt_icon":0},{"id":"2492414737","title":"诺和诺德将在新试验中探索 CagriSema 的减肥潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2492414737","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492414737?lang=zh_cn&edition=full","pubTime":"2024-12-20 20:09","pubTimestamp":1734696599,"startTime":"0","endTime":"0","summary":"路透哥本哈根12月20日 - 诺和诺德NOVOb.CO周五表示,该公司将在2025年上半年开始一项新的试验,进一步探索其试验性药物CagriSema的减肥潜力,此前该公司公布的候选药物数据令人失望 。周五早些时候,诺和诺德公司称,CagriSema在一项后期试验中帮助患者减轻了22.7%的体重,低于其预期的25%,这使其市值减少了多达1250亿美元。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nL4S3NL0RC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868836591.USD","LU1814569148.SGD","LU0417517546.SGD","SGXZ99366536.SGD","SG9999017495.SGD","LU0820561909.HKD","LU0672654240.SGD","LU1064131342.USD","IE00BK4W5M84.HKD","LLY","BK4585","LU1868836914.USD","SG9999014914.USD","LU1280957306.USD","LU0471298777.SGD","LU2468319806.SGD","LU0006306889.USD","LU2602419157.SGD","IE00BK4W5L77.USD","LU2023250504.SGD","IE00BJJMRZ35.SGD","SG9999013999.USD","SG9999014880.SGD","LU0061475181.USD","LU0320765059.SGD","BK4533","IE00BJT1NW94.SGD","LU2089984988.USD","LU2237443978.SGD","GB00BDT5M118.USD","LU1989771016.USD","BK4581","BK4007","LU2063271972.USD","SGXZ51526630.SGD","LU0198837287.USD","LU0122379950.USD","LU1366192091.USD","LU1623119135.USD","LU0882574055.USD","LU0640476718.USD","LU1061106388.HKD","LU2237443895.HKD","LU0689472784.USD","LU2361044949.HKD","SG9999015978.USD","LU1127390331.HKD","SG9999015986.USD","SG9999014898.SGD","LU0079474960.USD"],"gpt_icon":1},{"id":"2492414611","title":"BUZZ--美国股票走势-联邦快递、礼来公司、Aadi 生物科学公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2492414611","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492414611?lang=zh_cn&edition=full","pubTime":"2024-12-20 20:04","pubTimestamp":1734696255,"startTime":"0","endTime":"0","summary":"** 联邦快递 : BUZZ - 分析师认为联邦快递分拆货运卡车部门是有益的;上调PT ** Eli Lilly and Co : BUZZ - 诺和诺德的下一代肥胖症药物在研究中表现不佳,导致价格上涨 ** Humacyte : BUZZ - 因血管植入物获得 FDA 批准而上涨逾 40 ** 美国钢铁 : BUZZ - 在预测第四季度意外亏损后下跌 ** Aadi Bioscience : BUZZ - 因癌症药物许可协议而上涨 ** Viking Therapeutics :** Structure Therapeutics :** Altimmune :** 安进 : BUZZ - 诺和诺德的肥胖症药物在研究中表现不佳,减肥药开发商获得收益 ** Ionis Pharmaceuticals : BUZZ - 因FDA批准遗传性疾病药物而上涨","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HUMA","BK4588","LU0354030438.USD","SG9999017495.SGD","IE00B1BXHZ80.USD","LU0466842654.USD","LU1551013425.SGD","LU1814569148.SGD","IE00BJT1NW94.SGD","SG9999018857.SGD","BK4520","LU1061106388.HKD","LU1878469433.USD","AADI","SG9999001440.SGD","LU2265009873.SGD","LU0289739699.SGD","IE00B4R5TH58.HKD","LU0114720955.EUR","BK4585","LU0122379950.USD","LU2602419157.SGD","LU0079474960.USD","GPCR","AMGN","LU0058720904.USD","LU1064131342.USD","BK4599","X","LU0310800965.SGD","LU0820561909.HKD","LU0742534661.SGD","LU2089984988.USD","FDX","ALT","LU0238689110.USD","LU0471298694.HKD","LU1035775433.USD","IONS","LU1988902786.USD","LU0354030511.USD","LU1868836591.USD","BK4006","LU1868837300.USD","LU2360106947.USD","LU0882574139.USD","LU1093756325.SGD","LU0320765992.SGD","VKTX","LLY"],"gpt_icon":1},{"id":"2492241903","title":"BUZZ-诺和诺德肥胖症药物在研究中表现不佳,减肥药开发商获益匪浅","url":"https://stock-news.laohu8.com/highlight/detail?id=2492241903","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492241903?lang=zh_cn&edition=full","pubTime":"2024-12-20 19:40","pubTimestamp":1734694859,"startTime":"0","endTime":"0","summary":" 12月20日 - ** 诺和诺德公司的 下一代肥胖症实验药物在后期试验中的减重效果低于预期,一些减肥药开发商的股票在盘前上涨** 诺和诺德称其药物CagriSema帮助超重患者减轻了22.7%的体重 ,低于其25%的预期。** 诺和诺德在美国上市的股票下跌 22.4%,而竞争对手礼来 上涨 10** 投资者和分析师热切期待着这一数据,以检验诺和诺德是否拥有强大的药物管线,在竞争激烈的抗肥胖症市场上紧随Wegovy之后。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4de5f7200a34a5a69d5dce1d967bfe14","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BK4W5M84.HKD","LU0203202063.USD","LU0354030438.USD","LU1868836757.USD","LU1093756168.USD","LU1712237335.SGD","LU2237438978.USD","LU0096364046.USD","LU1814569148.SGD","IE00BJT1NW94.SGD","LU0198837287.USD","LU1804176565.USD","LU1551013342.USD","SGXZ57979304.SGD","LU0820561818.USD","LU1878469433.USD","LU0943347566.SGD","LU0640476718.USD","LU1291159041.SGD","LU0109391861.USD","LU2237443978.SGD","LU1868836914.USD","LU0385154629.USD","LU1983299246.USD","IE00BZ1G4Q59.USD","GPCR","LU0689472784.USD","AMGN","LU2242652126.USD","IE00BJJMRZ35.SGD","SG9999014898.SGD","IE00BKVL7J92.USD","LU0820561909.HKD","LU1623119135.USD","LU0471298777.SGD","LU2089984988.USD","LU2264538146.SGD","ALT","LU2461242641.AUD","LU2491050154.USD","LU2361044865.SGD","NVO","SG9999001176.SGD","LU0320765059.SGD","SG9999014906.USD","LU0882574139.USD","LU1571399168.USD","VKTX","LLY","LU0256863811.USD"],"gpt_icon":1},{"id":"2492141118","title":"礼来减肥药试验结果不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2492141118","media":"金吾资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492141118?lang=zh_cn&edition=full","pubTime":"2024-12-20 19:39","pubTimestamp":1734694791,"startTime":"0","endTime":"0","summary":"消息面上,美国食品和药物管理局宣布,制药巨头礼来公司减肥药Zepbound的活性成分司美格鲁肽不再短缺。此举意味着,FDA将不再允许复合药房生产未经批准的、无品牌、更便宜的tirzepatide仿制药版本。现在,FDA要求这些复合药房在接下来的60到90天内停止生产仿制版tirzepatide,具体期限取决于配药设施的类型。此外,其减肥药竞争对手诺和诺德,其实验性下一代减肥药CagriSema在后期试验中帮助超重患者减重22.7%,低于预期的25%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220194022a1fdb14b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220194022a1fdb14b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2324357040.USD","IE00BK4W5M84.HKD","BK4588","LU0354030438.USD","SG9999017495.SGD","IE00B1BXHZ80.USD","LU1712237335.SGD","SGXZ51526630.SGD","LU1551013425.SGD","LU0198837287.USD","LU1551013342.USD","SGXZ57979304.SGD","LU1061106388.HKD","LU2106854487.HKD","LU2265009873.SGD","LU0640476718.USD","LU1023059063.AUD","LU2361045086.USD","LU0289739699.SGD","IE00B4R5TH58.HKD","LU1291159041.SGD","LU2237443978.SGD","LU2237443382.USD","LU0708995401.HKD","LU1983299246.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","SG9999014898.SGD","LU0820561909.HKD","LU2089984988.USD","LU2264538146.SGD","LU0471298694.HKD","LU1035775433.USD","LU1069344957.HKD","BK4533","IE0009355771.USD","LU1988902786.USD","LU2361044865.SGD","NVO","IE00BK4W5L77.USD","LU0094547139.USD","LU0320765059.SGD","LU2211815571.USD","SG9999014906.USD","LU0882574139.USD","LU1093756325.SGD","SG9999014880.SGD","LU1623119135.USD","LU0203201768.USD","LU2237443622.USD","LLY"],"gpt_icon":0},{"id":"2492941971","title":"美股异动丨新药减重效果不及预期 诺和诺德盘前暴跌近30% 礼来涨超12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492941971","media":"港股那点事","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492941971?lang=zh_cn&edition=full","pubTime":"2024-12-20 19:24","pubTimestamp":1734693840,"startTime":"0","endTime":"0","summary":"诺和诺德(NVO.US)盘前一度暴跌近30%,其减肥药竞争对手礼来(LLY.US)盘前大涨超12%。诺和诺德周五表示,其实验性下一代减肥药CagriSema在后期试验中帮助超重患者减重22.7%,低于预期的25%。这一低于预期的数据对诺和诺德来说是一个打击,该公司原本希望CagriSema能成为比礼来的减肥药Zepbound更强大的产品,以接替其上一代减肥药Wegovy。投资者和分析师一直热切期待这些数据,以检验诺和诺德在激烈的抗肥胖市场竞争中是否拥有一个强大的后续产品来接替Wegovy。(格隆汇)\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a469344a0fb92d1bb998ed1b12947db3","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2024-12-20/doc-ineachkr5809184.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1868836757.USD","LU0289739699.SGD","LU2237443465.HKD","SG9999015978.USD","LU1291159041.SGD","LU1280957306.USD","SG9999014906.USD","LU0385154629.USD","LU0466842654.USD","LU1093756325.SGD","LU2237443978.SGD","IE00BZ1G4Q59.USD","IE00BFTCPJ56.SGD","BK4532","LU0061475181.USD","LU0122379950.USD","LU0820561909.HKD","LU1712237335.SGD","LU1551013342.USD","LU0354030511.USD","NVO","SG9999014898.SGD","LU0943347566.SGD","LU1989771016.USD","LU1868837136.USD","IE00BJLML261.HKD","LU0106261372.USD","LU1127390331.HKD","LU0109391861.USD","LU0154236417.USD","LU0820561818.USD","IE0004445239.USD","LU1868836591.USD","LU2324357040.USD","LU2265009873.SGD","BK4588","BK4533","LU1974910355.USD","LU1814569148.SGD","LU1868837300.USD","LU2023250504.SGD","BK4581","IE00BJJMRZ35.SGD","LU1093756168.USD","BK4534","LLY","LU0256863811.USD","SG9999018857.SGD","BK4516","LU0354030438.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lilly.com","stockEarnings":[{"period":"1week","weight":-0.0267},{"period":"1month","weight":0.0194},{"period":"3month","weight":-0.1665},{"period":"6month","weight":-0.1311},{"period":"1year","weight":0.3427},{"period":"ytd","weight":0.3176}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"礼来公司于1901年在印第安纳州注册成立,其前身是1876年由伊利·礼来上校在印第安纳州印第安纳波利斯创立的药品生产企业。公司发现,开发,制造和销售重要医药产品。公司的宗旨是将“关爱”与“发现”结合起来,为世界各地的人们创造更美好的生活。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.011498},{"month":2,"riseRate":0.5,"avgChangeRate":-0.002909},{"month":3,"riseRate":0.613636,"avgChangeRate":0.015389},{"month":4,"riseRate":0.555556,"avgChangeRate":0.018718},{"month":5,"riseRate":0.422222,"avgChangeRate":0.014916},{"month":6,"riseRate":0.6,"avgChangeRate":0.02296},{"month":7,"riseRate":0.555556,"avgChangeRate":-0.000346},{"month":8,"riseRate":0.422222,"avgChangeRate":0.004313},{"month":9,"riseRate":0.444444,"avgChangeRate":0.001418},{"month":10,"riseRate":0.577778,"avgChangeRate":0.012708},{"month":11,"riseRate":0.733333,"avgChangeRate":0.026326},{"month":12,"riseRate":0.577778,"avgChangeRate":0.030356}],"exchange":"NYSE","name":"礼来","nameEN":"Eli Lilly"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"礼来(LLY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供礼来(LLY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"礼来,LLY,礼来股票,礼来股票老虎,礼来股票老虎国际,礼来行情,礼来股票行情,礼来股价,礼来股市,礼来股票价格,礼来股票交易,礼来股票购买,礼来股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"礼来(LLY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供礼来(LLY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}